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Ming-Jang Hsieh, MD, Taiwan, Republic of China
Currently, a pulmonary homograft is preferred world-wide as the right ventricular outflow tract (RVOT)substitute in the Ross procedure. The lack of pulmo-nary homograft limits the use of the Ross procedure in
many parts of the world. To circumvent the problem, several
alternatives have been reported.1-6 The autologous pedicled peri-
cardial valved conduit (APPVC) has been reported as a modifica-
tion of the Rastelli procedure with the expectation of potential
conduit growth and low incidences of excessive peel formation
and thrombosis.7 In this article we present a case of RVOT
reconstruction with APPVC as the totally autologous Ross proce-
dure.
Clinical Summary
The patient was a 41-year-old man with a history of completely
treated streptococcal infective endocarditis 3 years previously. The
chest radiograph revealed moderate cardiomegaly, and the elec-
trocardiogram showed left ventricular hypertrophy. Echocardiog-
raphy demonstrated severe aortic regurgitation and a dilated left
ventricle.
The operation was performed with moderate hypothermic car-
diopulmonary bypass and antegrade cardioplegia. The pericardium
was incised along the right mediastinal margin to make a pedicled
rectangular flap. The flap was rolled up and sutured with inter-
rupted absorbable stitches to construct a conduit with a diameter of
25 mm. The caudal margin of the conduit was folded upward for
10 mm. The upper margin of the inner layer was secured to the
outer layer at three equidistant points, to become the future valve
commissures (Figure 1).
The Ross procedure was completed in the usual manner. The
APPVC was then used for the RVOT reconstruction. With 5-0
absorbable monofilament running sutures, the distal end of the
conduit was anastomosed to the pulmonary artery. The proximal
anastomosis was created with the interposition of a short segment
of autologous aortic tube between the conduit and the RVOT,
because this required less suturing and no prosthetic conduit had a
subvalvular or anterior hood segment (Figure 2).
The postoperative course was uneventful. At 36 months after
the operation, the patient was well. Serial echocardiographic
follow-up revealed stable valvular condition with mild pulmonary
stenosis (the Doppler echocardiographic mean gradient was 22
mm Hg) and regurgitation. The aortic valve was satisfactory (triv-
ial aortic regurgitation without any pressure gradient).
Discussion
Currently, indications for the Ross procedure are expanding. Au-
tografts show excellent longevity, clear hemodynamic superiority,
infection resistance, and freedom from anticoagulation. These
characteristics are attractive, even though the procedure is complex
and time-consuming. A pulmonary homograft is accepted world-
wide as the material most useful for the RVOT reconstruction in
Ross procedure. Although a pulmonary homograft is preferred and
lasts longer in the pulmonary position, replacement nevertheless
will be needed. Furthermore, developing countries where ho-
mografts are not available do not currently have an acceptable
alternative. To circumvent those problems, numerous types of
conduits have been developed, each with its own advantages and
disadvantages, to connect the right ventricle to the pulmonary
artery.
Most of these alternatives are composite grafts of autologous
tissue and artificial materials (polytetrafluoroethylene) or porcine
bioprostheses.1-6 They have their own limitations with respect to
growth potential or valvular competency. In contrast, the APPVC
seems to circumvent these problems in most cases.
Our technique does raise several issues. First, the use of autol-
ogous pedicled pericardial conduit is important. It has been re-
ported that RVOT reconstruction with autologous pedicled peri-
cardium is useful to prevent late stenosis, because the pedicled
pericardium is more pliable and less fibrotic.8 Therefore this con-
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duit is expected to have good longevity. Another issue is the role
of the pericardial tricuspid valve. Usually, a tricuspid valve is
considered more effective than a monocuspid valve in preventing
pulmonary regurgitation. To avoid cusp adhesion to the conduit
wall, we used no prosthetic material. Therefore the pericardial flap
should be as long as possible, and potential growth of the valved
conduit may be expected.7
In conclusion, we emphasize that the APPVC may be a good
alternative for RVOT reconstruction in the Ross procedure. It
provides the expectation of a functioning tricuspid pericardial
valve, prevention of late stenosis, and potential conduit growth.
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Figure 2. Short segment of autologous aortic tube interposed
between conduit and right ventricle.
Figure 1. Competent APPVC.
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